Jinhai Medical Technology (HKSE:02225) ROCE % : -21.53% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Jinhai Medical Technology ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Jinhai Medical Technology's annualized ROCE % for the quarter that ended in Dec. 2023 was -21.53%.

Jinhai Medical Technology ROCE % Historical Data

The historical data trend for Jinhai Medical Technology's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jinhai Medical Technology ROCE % Chart

Jinhai Medical Technology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

1.92

6.43

0.28

3.45

-8.97

Jinhai Medical Technology Semi-Annual Data
	Dec14	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial												-5.95	13.05	-6.05	4.84	-21.53

Jinhai Medical Technology ROCE % Calculation

Jinhai Medical Technology's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-17.565	/	( ( (231.932 - 80.618)	+	(364.782 - 124.596) )	/ 2 )
	=	-17.565	/	( (151.314	+	240.186)	/ 2 )
	=	-17.565	/	195.75
	=	-8.97 %

Jinhai Medical Technology's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	-42.61	/	( ( (273.445 - 117.832)	+	(364.782 - 124.596) )	/ 2 )
	=	-42.61	/	( ( 155.613	+	240.186 )	/ 2 )
	=	-42.61	/	197.8995
	=	-21.53 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Jinhai Medical Technology (HKSE:02225) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Jinhai Medical Technology ROCE % Related Terms

Thank you for viewing the detailed overview of Jinhai Medical Technology's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Jinhai Medical Technology (HKSE:02225) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Jinhai Medical Technology Ltd (HKSE:02225) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

31 Sungei Kadut Avenue, Singapore, SGP, 729660

Website

https://www.jin-hai.com.hk

Jinhai International Group Holdings Ltd is a Singapore-based company engaged in the provision of manpower outsourcing and ancillary services to building and construction contractors in Singapore. It also provides dormitory services, IT services, and construction ancillary services including warehousing services, cleaning services, and building maintenance work in Singapore. It earns a vast majority of its revenues from the Manpower outsourcing and ancillary services segment.

Executives

Liu Lei	2101 Beneficial owner
Chen Guobao	2201 Interest of corporation controlled by you
Full Fortune International Co., Ltd.	2101 Beneficial owner
Jiang Xiahong	2202 Interest of your spouse

Jinhai Medical Technology (HKSE:02225) Headlines

No Headlines